posted
ENDP Looks like capitulation on the daily, hourly stochastics and RSI still extremely oversold but started Making the turn with nice volume bars eod. Form 4's show insiders buying shares all week. Will look to add calls to go with my common on a higher high on the daily tomorrow or early next week...
IP: Logged |
posted
SYNC $3.20's with room to add dips. Lots of good news last two weeks, looks cheap when you factor in the forecasted growth next 2-3 years. Stock is still consolidating the big move off AT&T news. Trades thin, $4 break will light it up. Patience will be rewarded here imo
IP: Logged |
posted
ENDP $15.55...Taking some common off here ahead of the Fed to cover the cost basis of my options. Will let my calls do the heavy lifting from here...
IP: Logged |
posted
SRCL quietly trending up all morning...Added calls on this mornings retest of the 5 EMA and will add again on a break of yesterdays highs...
IP: Logged |
posted
SRCL $96.70's, pretty weak in a strong tape today. Giving this a little more leash than I normally would. Strong sweeps into weakness with the June calls again yesterday. I'll give this one some more time to play out...
IP: Logged |
posted
VGK $49.20's...Popping up on one of my screeners this afternoon. Lots of volume in the July $50 calls, my time and sales shows14k @ .65 and 6k @ .70 vs. no OI...Worth watching IMO
IP: Logged |
quote:Originally posted by Happy Valley: XBI $54 handle. Peeps who followed into that sweep are getting paid today, looking for much more heading into ASCO...
posted
Big call blocks in SRCL again today...Aug $105's, 12,670 vs. OI of 34...Interesting timing with annual shareholder meeting scheduled for today.
IP: Logged |
posted
INSM $11.90...Big call volume in the July $12's
EMA regulatory review of ARIKAYCE progressing. The company remains on track with previous guidance, having submitted its responses to the European Medicine Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) 180-day list of outstanding issues related to the company’s Marketing Authorization Application (MAA) for ARIKAYCE. Insmed expects to participate in an oral explanation meeting in the second quarter of 2016 and the CHMP to render an opinion on its MAA around the middle of 2016. http://finance.yahoo.com/news/insmed-reports-first-quarter-2016-120300632.html
IP: Logged |
Popped up on a volume screener this afternoon, 4.8M today vs. 3m adv. of 230k. RSI on the daily @ 7 and MACD Getting close to turning positive. Worth watching IMO